Application no. and date | 15774282.6 (espacenet) (Federated) (European Patent Register), 20150327 | Patent/reg. no. and date | DK/EP 3125894, 20200909 | Publication date | 20170208 | Priority no. and date | US 201461973689 P, 20140401 | EP pub. no. and date |
EP 3125894 20170208 | Effective date | | Applicant/owner | Merck Sharp & Dohme LLC, 126 East Lincoln Avenue Rahway, New Jersey 07065, US | Applicant ref. no. | V155778DK | Inventor | BURGEY, Christopher, S., 770 Sumneytown Pike
West Point, Pennsylvania 19486, US, PATEL, Mehul, 770 Sumneytown Pike
West Point, Pennsylvania 19486, US, FRITZEN, Jeffrey, F., 154 Micklitz Drive
Pottstown, Pennsylvania 19464, US, BALSELLS, Jaume, 770 Sumneytown Pike
West Point, Pennsylvania 19486, US | Representative | Marks & Clerk LLP, 44 rue de la Vallée
BP 1775
L-1017 Luxembourg, LU | Opponent | | IPC Class | A61K 31/501 (2006.01) , A61K 31/506 (2006.01) , A61K 31/513 (2006.01) , A61K 45/06 (2006.01) , A61P 31/18 (2006.01) , C07D 403/06 (2006.01) | Title | PRODRUGS AF HIV-REVERSTRANSCRIPTASEHÆMMERE | Int. application no. | US2015022868 | Int. publication no. | WO2015153304 | Related patent (certificate) | | Status | DK/EP patent | Pædiatrisk forlængelse | - | Udløbsdato for pædiatrisk forlængelse | - |
|